img

Global Oral Anti-Diabetic Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oral Anti-Diabetic Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Anti-diabetic drug refers to the medications consumed orally that are prescribed to treat diabetes mellitus (type 2). It treats diabetes (type 2) by lowering down the blood sugar level. These are also known as oral hypoglycemic agents or oral antihyperglycemic agents. Oral anti-diabetic drugs are often prescribed as monotherapy but in severe cases, can be given in combination with insulin.
Oral Anti-Diabetic Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Oral Anti-Diabetic Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Research Institual are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Oral Anti-Diabetic Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Oral Anti-Diabetic Drug key manufacturers include Takeda, Pfizer, Eli Lilly, Janssen Pharmaceuticals, Astellas, Boehringer Ingelheim, Merck And Co., AstraZeneca and Bristol Myers Squibb, etc. Takeda, Pfizer, Eli Lilly are top 3 players and held % sales share in total in 2022.
Oral Anti-Diabetic Drug can be divided into Glimepiride, Gliclazide, Glyburide and Others, etc. Glimepiride is the mainstream product in the market, accounting for % sales share globally in 2022.
Oral Anti-Diabetic Drug is widely used in various fields, such as Hospital and Research Institual, etc. Hospital provides greatest supports to the Oral Anti-Diabetic Drug industry development. In 2022, global % sales of Oral Anti-Diabetic Drug went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Anti-Diabetic Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Takeda
Pfizer
Eli Lilly
Janssen Pharmaceuticals
Astellas
Boehringer Ingelheim
Merck And Co.
AstraZeneca
Bristol Myers Squibb
Novartis
Sanofi
Abbott
Biocon
Segment by Type
Glimepiride
Gliclazide
Glyburide
Others

Segment by Application


Hospital
Research Institual

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Oral Anti-Diabetic Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oral Anti-Diabetic Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oral Anti-Diabetic Drug industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Oral Anti-Diabetic Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oral Anti-Diabetic Drug introduction, etc. Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Oral Anti-Diabetic Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Oral Anti-Diabetic Drug Market Overview
1.1 Oral Anti-Diabetic Drug Product Overview
1.2 Oral Anti-Diabetic Drug Market Segment by Type
1.2.1 Glimepiride
1.2.2 Gliclazide
1.2.3 Glyburide
1.2.4 Others
1.3 Global Oral Anti-Diabetic Drug Market Size by Type
1.3.1 Global Oral Anti-Diabetic Drug Market Size Overview by Type (2024-2034)
1.3.2 Global Oral Anti-Diabetic Drug Historic Market Size Review by Type (2024-2024)
1.3.3 Global Oral Anti-Diabetic Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Oral Anti-Diabetic Drug Sales Breakdown by Type (2024-2024)
1.4.2 Europe Oral Anti-Diabetic Drug Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Oral Anti-Diabetic Drug Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Oral Anti-Diabetic Drug Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Oral Anti-Diabetic Drug Sales Breakdown by Type (2024-2024)
2 Global Oral Anti-Diabetic Drug Market Competition by Company
2.1 Global Top Players by Oral Anti-Diabetic Drug Sales (2024-2024)
2.2 Global Top Players by Oral Anti-Diabetic Drug Revenue (2024-2024)
2.3 Global Top Players by Oral Anti-Diabetic Drug Price (2024-2024)
2.4 Global Top Manufacturers Oral Anti-Diabetic Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Oral Anti-Diabetic Drug Market Competitive Situation and Trends
2.5.1 Oral Anti-Diabetic Drug Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Oral Anti-Diabetic Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Anti-Diabetic Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Oral Anti-Diabetic Drug Market
2.8 Key Manufacturers Oral Anti-Diabetic Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Oral Anti-Diabetic Drug Status and Outlook by Region
3.1 Global Oral Anti-Diabetic Drug Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Oral Anti-Diabetic Drug Historic Market Size by Region
3.2.1 Global Oral Anti-Diabetic Drug Sales in Volume by Region (2024-2024)
3.2.2 Global Oral Anti-Diabetic Drug Sales in Value by Region (2024-2024)
3.2.3 Global Oral Anti-Diabetic Drug Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Oral Anti-Diabetic Drug Forecasted Market Size by Region
3.3.1 Global Oral Anti-Diabetic Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Oral Anti-Diabetic Drug Sales in Value by Region (2024-2034)
3.3.3 Global Oral Anti-Diabetic Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Oral Anti-Diabetic Drug by Application
4.1 Oral Anti-Diabetic Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Research Institual
4.2 Global Oral Anti-Diabetic Drug Market Size by Application
4.2.1 Global Oral Anti-Diabetic Drug Market Size Overview by Application (2024-2034)
4.2.2 Global Oral Anti-Diabetic Drug Historic Market Size Review by Application (2024-2024)
4.2.3 Global Oral Anti-Diabetic Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Oral Anti-Diabetic Drug Sales Breakdown by Application (2024-2024)
4.3.2 Europe Oral Anti-Diabetic Drug Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Oral Anti-Diabetic Drug Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Oral Anti-Diabetic Drug Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Oral Anti-Diabetic Drug Sales Breakdown by Application (2024-2024)
5 North America Oral Anti-Diabetic Drug by Country
5.1 North America Oral Anti-Diabetic Drug Historic Market Size by Country
5.1.1 North America Oral Anti-Diabetic Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Oral Anti-Diabetic Drug Sales in Volume by Country (2024-2024)
5.1.3 North America Oral Anti-Diabetic Drug Sales in Value by Country (2024-2024)
5.2 North America Oral Anti-Diabetic Drug Forecasted Market Size by Country
5.2.1 North America Oral Anti-Diabetic Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Oral Anti-Diabetic Drug Sales in Value by Country (2024-2034)
6 Europe Oral Anti-Diabetic Drug by Country
6.1 Europe Oral Anti-Diabetic Drug Historic Market Size by Country
6.1.1 Europe Oral Anti-Diabetic Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Oral Anti-Diabetic Drug Sales in Volume by Country (2024-2024)
6.1.3 Europe Oral Anti-Diabetic Drug Sales in Value by Country (2024-2024)
6.2 Europe Oral Anti-Diabetic Drug Forecasted Market Size by Country
6.2.1 Europe Oral Anti-Diabetic Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Oral Anti-Diabetic Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Oral Anti-Diabetic Drug by Region
7.1 Asia-Pacific Oral Anti-Diabetic Drug Historic Market Size by Region
7.1.1 Asia-Pacific Oral Anti-Diabetic Drug Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Oral Anti-Diabetic Drug Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Oral Anti-Diabetic Drug Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Oral Anti-Diabetic Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Oral Anti-Diabetic Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Oral Anti-Diabetic Drug Sales in Value by Region (2024-2034)
8 Latin America Oral Anti-Diabetic Drug by Country
8.1 Latin America Oral Anti-Diabetic Drug Historic Market Size by Country
8.1.1 Latin America Oral Anti-Diabetic Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Oral Anti-Diabetic Drug Sales in Volume by Country (2024-2024)
8.1.3 Latin America Oral Anti-Diabetic Drug Sales in Value by Country (2024-2024)
8.2 Latin America Oral Anti-Diabetic Drug Forecasted Market Size by Country
8.2.1 Latin America Oral Anti-Diabetic Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Oral Anti-Diabetic Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Oral Anti-Diabetic Drug by Country
9.1 Middle East and Africa Oral Anti-Diabetic Drug Historic Market Size by Country
9.1.1 Middle East and Africa Oral Anti-Diabetic Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Oral Anti-Diabetic Drug Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Oral Anti-Diabetic Drug Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Oral Anti-Diabetic Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Oral Anti-Diabetic Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Oral Anti-Diabetic Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Takeda
10.1.1 Takeda Company Information
10.1.2 Takeda Introduction and Business Overview
10.1.3 Takeda Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Takeda Oral Anti-Diabetic Drug Products Offered
10.1.5 Takeda Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Pfizer Oral Anti-Diabetic Drug Products Offered
10.2.5 Pfizer Recent Development
10.3 Eli Lilly
10.3.1 Eli Lilly Company Information
10.3.2 Eli Lilly Introduction and Business Overview
10.3.3 Eli Lilly Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Eli Lilly Oral Anti-Diabetic Drug Products Offered
10.3.5 Eli Lilly Recent Development
10.4 Janssen Pharmaceuticals
10.4.1 Janssen Pharmaceuticals Company Information
10.4.2 Janssen Pharmaceuticals Introduction and Business Overview
10.4.3 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Products Offered
10.4.5 Janssen Pharmaceuticals Recent Development
10.5 Astellas
10.5.1 Astellas Company Information
10.5.2 Astellas Introduction and Business Overview
10.5.3 Astellas Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Astellas Oral Anti-Diabetic Drug Products Offered
10.5.5 Astellas Recent Development
10.6 Boehringer Ingelheim
10.6.1 Boehringer Ingelheim Company Information
10.6.2 Boehringer Ingelheim Introduction and Business Overview
10.6.3 Boehringer Ingelheim Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Boehringer Ingelheim Oral Anti-Diabetic Drug Products Offered
10.6.5 Boehringer Ingelheim Recent Development
10.7 Merck And Co.
10.7.1 Merck And Co. Company Information
10.7.2 Merck And Co. Introduction and Business Overview
10.7.3 Merck And Co. Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Merck And Co. Oral Anti-Diabetic Drug Products Offered
10.7.5 Merck And Co. Recent Development
10.8 AstraZeneca
10.8.1 AstraZeneca Company Information
10.8.2 AstraZeneca Introduction and Business Overview
10.8.3 AstraZeneca Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.8.4 AstraZeneca Oral Anti-Diabetic Drug Products Offered
10.8.5 AstraZeneca Recent Development
10.9 Bristol Myers Squibb
10.9.1 Bristol Myers Squibb Company Information
10.9.2 Bristol Myers Squibb Introduction and Business Overview
10.9.3 Bristol Myers Squibb Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Bristol Myers Squibb Oral Anti-Diabetic Drug Products Offered
10.9.5 Bristol Myers Squibb Recent Development
10.10 Novartis
10.10.1 Novartis Company Information
10.10.2 Novartis Introduction and Business Overview
10.10.3 Novartis Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Novartis Oral Anti-Diabetic Drug Products Offered
10.10.5 Novartis Recent Development
10.11 Sanofi
10.11.1 Sanofi Company Information
10.11.2 Sanofi Introduction and Business Overview
10.11.3 Sanofi Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Sanofi Oral Anti-Diabetic Drug Products Offered
10.11.5 Sanofi Recent Development
10.12 Abbott
10.12.1 Abbott Company Information
10.12.2 Abbott Introduction and Business Overview
10.12.3 Abbott Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Abbott Oral Anti-Diabetic Drug Products Offered
10.12.5 Abbott Recent Development
10.13 Biocon
10.13.1 Biocon Company Information
10.13.2 Biocon Introduction and Business Overview
10.13.3 Biocon Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Biocon Oral Anti-Diabetic Drug Products Offered
10.13.5 Biocon Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Oral Anti-Diabetic Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Oral Anti-Diabetic Drug Industrial Chain Analysis
11.4 Oral Anti-Diabetic Drug Market Dynamics
11.4.1 Oral Anti-Diabetic Drug Industry Trends
11.4.2 Oral Anti-Diabetic Drug Market Drivers
11.4.3 Oral Anti-Diabetic Drug Market Challenges
11.4.4 Oral Anti-Diabetic Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Oral Anti-Diabetic Drug Distributors
12.3 Oral Anti-Diabetic Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Glimepiride
Table 2. Major Company of Gliclazide
Table 3. Major Company of Glyburide
Table 4. Major Company of Others
Table 5. Global Oral Anti-Diabetic Drug Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Oral Anti-Diabetic Drug Sales by Type (2024-2024) & (K Tons)
Table 7. Global Oral Anti-Diabetic Drug Sales Market Share in Volume by Type (2024-2024)
Table 8. Global Oral Anti-Diabetic Drug Sales by Type (2024-2024) & (US& Million)
Table 9. Global Oral Anti-Diabetic Drug Market Share in Value by Type (2024-2024)
Table 10. Global Oral Anti-Diabetic Drug Price by Type (2024-2024) & (USD/Ton)
Table 11. Global Oral Anti-Diabetic Drug Sales by Type (2024-2034) & (K Tons)
Table 12. Global Oral Anti-Diabetic Drug Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Oral Anti-Diabetic Drug Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Oral Anti-Diabetic Drug Sales Market Share in Value by Type (2024-2034)
Table 15. Global Oral Anti-Diabetic Drug Price by Type (2024-2034) & (USD/Ton)
Table 16. North America Oral Anti-Diabetic Drug Sales by Type (2024-2024) & (K Tons)
Table 17. North America Oral Anti-Diabetic Drug Sales by Type (2024-2024) & (US$ Million)
Table 18. Europe Oral Anti-Diabetic Drug Sales (K Tons) by Type (2024-2024)
Table 19. Europe Oral Anti-Diabetic Drug Sales by Type (2024-2024) & (US$ Million)
Table 20. Asia-Pacific Oral Anti-Diabetic Drug Sales (K Tons) by Type (2024-2024)
Table 21. Asia-Pacific Oral Anti-Diabetic Drug Sales by Type (2024-2024) & (US$ Million)
Table 22. Latin America Oral Anti-Diabetic Drug Sales (K Tons) by Type (2024-2024)
Table 23. Latin America Oral Anti-Diabetic Drug Sales by Type (2024-2024) & (US$ Million)
Table 24. Middle East and Africa Oral Anti-Diabetic Drug Sales (K Tons) by Type (2024-2024)
Table 25. Middle East and Africa Oral Anti-Diabetic Drug Sales by Type (2024-2024) & (US$ Million)
Table 26. Global Oral Anti-Diabetic Drug Sales by Company (2024-2024) & (K Tons)
Table 27. Global Oral Anti-Diabetic Drug Sales Share by Company (2024-2024)
Table 28. Global Oral Anti-Diabetic Drug Revenue by Company (2024-2024) & (US$ Million)
Table 29. Global Oral Anti-Diabetic Drug Revenue Share by Company (2024-2024)
Table 30. Global Market Oral Anti-Diabetic Drug Price by Company (2024-2024) & (USD/Ton)
Table 31. Global Oral Anti-Diabetic Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Oral Anti-Diabetic Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Anti-Diabetic Drug as of 2022)
Table 34. Date of Key Manufacturers Enter into Oral Anti-Diabetic Drug Market
Table 35. Key Manufacturers Oral Anti-Diabetic Drug Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Oral Anti-Diabetic Drug Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Global Oral Anti-Diabetic Drug Sales by Region (2024-2024) & (K Tons)
Table 39. Global Oral Anti-Diabetic Drug Sales Market Share in Volume by Region (2024-2024)
Table 40. Global Oral Anti-Diabetic Drug Sales by Region (2024-2024) & (US$ Million)
Table 41. Global Oral Anti-Diabetic Drug Sales Market Share in Value by Region (2024-2024)
Table 42. Global Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2024-2024)
Table 43. Global Oral Anti-Diabetic Drug Sales by Region (2024-2034) & (K Tons)
Table 44. Global Oral Anti-Diabetic Drug Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Oral Anti-Diabetic Drug Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Oral Anti-Diabetic Drug Sales Market Share in Value by Region (2024-2034)
Table 47. Global Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2024-2034)
Table 48. Global Oral Anti-Diabetic Drug Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 49. Global Oral Anti-Diabetic Drug Sales by Application (2024-2024) & (K Tons)
Table 50. Global Oral Anti-Diabetic Drug Sales Market Share in Volume by Application (2024-2024)
Table 51. Global Oral Anti-Diabetic Drug Sales by Application (2024-2024) & (US$ Million)
Table 52. Global Oral Anti-Diabetic Drug Sales Market Share in Value by Application (2024-2024)
Table 53. Global Oral Anti-Diabetic Drug Price by Application (2024-2024) & (USD/Ton)
Table 54. Global Oral Anti-Diabetic Drug Sales by Application (2024-2034) & (K Tons)
Table 55. Global Oral Anti-Diabetic Drug Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Oral Anti-Diabetic Drug Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Oral Anti-Diabetic Drug Sales Market Share in Value by Application (2024-2034)
Table 58. Global Oral Anti-Diabetic Drug Price by Application (2024-2034) & (USD/Ton)
Table 59. North America Oral Anti-Diabetic Drug Sales by Application (2024-2024) (K Tons)
Table 60. North America Oral Anti-Diabetic Drug Sales by Application (2024-2024) & (US$ Million)
Table 61. Europe Oral Anti-Diabetic Drug Sales by Application (2024-2024) (K Tons)
Table 62. Europe Oral Anti-Diabetic Drug Sales by Application (2024-2024) & (US$ Million)
Table 63. Asia-Pacific Oral Anti-Diabetic Drug Sales by Application (2024-2024) (K Tons)
Table 64. Asia-Pacific Oral Anti-Diabetic Drug Sales by Application (2024-2024) & (US$ Million)
Table 65. Latin America Oral Anti-Diabetic Drug Sales by Application (2024-2024) (K Tons)
Table 66. Latin America Oral Anti-Diabetic Drug Sales by Application (2024-2024) & (US$ Million)
Table 67. Middle East and Africa Oral Anti-Diabetic Drug Sales by Application (2024-2024) (K Tons)
Table 68. Middle East and Africa Oral Anti-Diabetic Drug Sales by Application (2024-2024) & (US$ Million)
Table 69. North America Oral Anti-Diabetic Drug Sales by Country (2024-2024) & (K Tons)
Table 70. North America Oral Anti-Diabetic Drug Sales Market Share in Volume by Country (2024-2024)
Table 71. North America Oral Anti-Diabetic Drug Sales by Country (2024-2024) & (US$ Million)
Table 72. North America Oral Anti-Diabetic Drug Sales Market Share in Value by Country (2024-2024)
Table 73. North America Oral Anti-Diabetic Drug Sales by Country (2024-2034) & (K Tons)
Table 74. North America Oral Anti-Diabetic Drug Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Oral Anti-Diabetic Drug Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Oral Anti-Diabetic Drug Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Oral Anti-Diabetic Drug Sales by Country (2024-2024) & (K Tons)
Table 78. Europe Oral Anti-Diabetic Drug Sales Market Share in Volume by Country (2024-2024)
Table 79. Europe Oral Anti-Diabetic Drug Sales by Country (2024-2024) & (US$ Million)
Table 80. Europe Oral Anti-Diabetic Drug Sales Market Share in Value by Country (2024-2024)
Table 81. Europe Oral Anti-Diabetic Drug Sales by Country (2024-2034) & (K Tons)
Table 82. Europe Oral Anti-Diabetic Drug Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Oral Anti-Diabetic Drug Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Oral Anti-Diabetic Drug Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Oral Anti-Diabetic Drug Sales by Region (2024-2024) & (K Tons)
Table 86. Asia-Pacific Oral Anti-Diabetic Drug Sales Market Share in Volume by Region (2024-2024)
Table 87. Asia-Pacific Oral Anti-Diabetic Drug Sales by Region (2024-2024) & (US$ Million)
Table 88. Asia-Pacific Oral Anti-Diabetic Drug Sales Market Share in Value by Region (2024-2024)
Table 89. Asia-Pacific Oral Anti-Diabetic Drug Sales by Region (2024-2034) & (K Tons)
Table 90. Asia-Pacific Oral Anti-Diabetic Drug Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Oral Anti-Diabetic Drug Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Oral Anti-Diabetic Drug Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Oral Anti-Diabetic Drug Sales by Country (2024-2024) & (K Tons)
Table 94. Latin America Oral Anti-Diabetic Drug Sales Market Share in Volume by Country (2024-2024)
Table 95. Latin America Oral Anti-Diabetic Drug Sales by Country (2024-2024) & (US$ Million)
Table 96. Latin America Oral Anti-Diabetic Drug Sales Market Share in Value by Country (2024-2024)
Table 97. Latin America Oral Anti-Diabetic Drug Sales by Country (2024-2034) & (K Tons)
Table 98. Latin America Oral Anti-Diabetic Drug Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Oral Anti-Diabetic Drug Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Oral Anti-Diabetic Drug Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Oral Anti-Diabetic Drug Sales by Country (2024-2024) & (K Tons)
Table 102. Middle East and Africa Oral Anti-Diabetic Drug Sales Market Share in Volume by Country (2024-2024)
Table 103. Middle East and Africa Oral Anti-Diabetic Drug Sales by Country (2024-2024) & (US$ Million)
Table 104. Middle East and Africa Oral Anti-Diabetic Drug Sales Market Share in Value by Country (2024-2024)
Table 105. Middle East and Africa Oral Anti-Diabetic Drug Sales by Country (2024-2034) & (K Tons)
Table 106. Middle East and Africa Oral Anti-Diabetic Drug Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Oral Anti-Diabetic Drug Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Oral Anti-Diabetic Drug Sales Market Share in Value by Country (2024-2034)
Table 109. Takeda Company Information
Table 110. Takeda Introduction and Business Overview
Table 111. Takeda Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2024-2024)
Table 112. Takeda Oral Anti-Diabetic Drug Product
Table 113. Takeda Recent Development
Table 114. Pfizer Company Information
Table 115. Pfizer Introduction and Business Overview
Table 116. Pfizer Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2024-2024)
Table 117. Pfizer Oral Anti-Diabetic Drug Product
Table 118. Pfizer Recent Development
Table 119. Eli Lilly Company Information
Table 120. Eli Lilly Introduction and Business Overview
Table 121. Eli Lilly Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2024-2024)
Table 122. Eli Lilly Oral Anti-Diabetic Drug Product
Table 123. Eli Lilly Recent Development
Table 124. Janssen Pharmaceuticals Company Information
Table 125. Janssen Pharmaceuticals Introduction and Business Overview
Table 126. Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2024-2024)
Table 127. Janssen Pharmaceuticals Oral Anti-Diabetic Drug Product
Table 128. Janssen Pharmaceuticals Recent Development
Table 129. Astellas Company Information
Table 130. Astellas Introduction and Business Overview
Table 131. Astellas Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2024-2024)
Table 132. Astellas Oral Anti-Diabetic Drug Product
Table 133. Astellas Recent Development
Table 134. Boehringer Ingelheim Company Information
Table 135. Boehringer Ingelheim Introduction and Business Overview
Table 136. Boehringer Ingelheim Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2024-2024)
Table 137. Boehringer Ingelheim Oral Anti-Diabetic Drug Product
Table 138. Boehringer Ingelheim Recent Development
Table 139. Merck And Co. Company Information
Table 140. Merck And Co. Introduction and Business Overview
Table 141. Merck And Co. Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2024-2024)
Table 142. Merck And Co. Oral Anti-Diabetic Drug Product
Table 143. Merck And Co. Recent Development
Table 144. AstraZeneca Company Information
Table 145. AstraZeneca Introduction and Business Overview
Table 146. AstraZeneca Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2024-2024)
Table 147. AstraZeneca Oral Anti-Diabetic Drug Product
Table 148. AstraZeneca Recent Development
Table 149. Bristol Myers Squibb Company Information
Table 150. Bristol Myers Squibb Introduction and Business Overview
Table 151. Bristol Myers Squibb Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2024-2024)
Table 152. Bristol Myers Squibb Oral Anti-Diabetic Drug Product
Table 153. Bristol Myers Squibb Recent Development
Table 154. Novartis Company Information
Table 155. Novartis Introduction and Business Overview
Table 156. Novartis Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2024-2024)
Table 157. Novartis Oral Anti-Diabetic Drug Product
Table 158. Novartis Recent Development
Table 159. Sanofi Company Information
Table 160. Sanofi Introduction and Business Overview
Table 161. Sanofi Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2024-2024)
Table 162. Sanofi Oral Anti-Diabetic Drug Product
Table 163. Sanofi Recent Development
Table 164. Abbott Company Information
Table 165. Abbott Introduction and Business Overview
Table 166. Abbott Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2024-2024)
Table 167. Abbott Oral Anti-Diabetic Drug Product
Table 168. Abbott Recent Development
Table 169. Biocon Company Information
Table 170. Biocon Introduction and Business Overview
Table 171. Biocon Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2024-2024)
Table 172. Biocon Oral Anti-Diabetic Drug Product
Table 173. Biocon Recent Development
Table 174. Key Raw Materials Lists
Table 175. Raw Materials Key Suppliers Lists
Table 176. Oral Anti-Diabetic Drug Market Trends
Table 177. Oral Anti-Diabetic Drug Market Drivers
Table 178. Oral Anti-Diabetic Drug Market Challenges
Table 179. Oral Anti-Diabetic Drug Market Restraints
Table 180. Oral Anti-Diabetic Drug Distributors List
Table 181. Oral Anti-Diabetic Drug Downstream Customers
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Anti-Diabetic Drug Product Picture
Figure 2. Global Oral Anti-Diabetic Drug Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Oral Anti-Diabetic Drug Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Oral Anti-Diabetic Drug Sales Status and Outlook (2024-2034) & (K Tons)
Figure 5. Product Picture of Glimepiride
Figure 6. Global Glimepiride Sales YoY Growth (2024-2034) & (K Tons)
Figure 7. Product Picture of Gliclazide
Figure 8. Global Gliclazide Sales YoY Growth (2024-2034) & (K Tons)
Figure 9. Product Picture of Glyburide
Figure 10. Global Glyburide Sales YoY Growth (2024-2034) & (K Tons)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2024-2034) & (K Tons)
Figure 13. Global Oral Anti-Diabetic Drug Sales by Type (2024-2034) & (US$ Million)
Figure 14. Global Oral Anti-Diabetic Drug Sales Market Share by Type in 2022 & 2034
Figure 15. North America Oral Anti-Diabetic Drug Sales Market Share in Volume by Type in 2022
Figure 16. North America Oral Anti-Diabetic Drug Sales Market Share in Value by Type in 2022
Figure 17. Europe Oral Anti-Diabetic Drug Sales Market Share in Volume by Type in 2022
Figure 18. Europe Oral Anti-Diabetic Drug Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Oral Anti-Diabetic Drug Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Oral Anti-Diabetic Drug Sales Market Share in Value by Type in 2022
Figure 21. Latin America Oral Anti-Diabetic Drug Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Oral Anti-Diabetic Drug Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Oral Anti-Diabetic Drug Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Oral Anti-Diabetic Drug Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Anti-Diabetic Drug Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Anti-Diabetic Drug Revenue in 2022
Figure 27. Oral Anti-Diabetic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 28. Product Picture of Hospital
Figure 29. Global Hospital Sales YoY Growth (2024-2034) & (K Tons)
Figure 30. Product Picture of Research Institual
Figure 31. Global Research Institual Sales YoY Growth (2024-2034) & (K Tons)
Figure 32. Global Oral Anti-Diabetic Drug Sales by Application (2024-2034) & (US$ Million)
Figure 33. Global Oral Anti-Diabetic Drug Sales Market Share by Application in 2022 & 2034
Figure 34. North America Oral Anti-Diabetic Drug Sales Market Share in Volume by Application in 2022
Figure 35. North America Oral Anti-Diabetic Drug Sales Market Share in Value by Application in 2022
Figure 36. Europe Oral Anti-Diabetic Drug Sales Market Share in Volume by Application in 2022
Figure 37. Europe Oral Anti-Diabetic Drug Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Oral Anti-Diabetic Drug Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Oral Anti-Diabetic Drug Sales Market Share in Value by Application in 2022
Figure 40. Latin America Oral Anti-Diabetic Drug Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Oral Anti-Diabetic Drug Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Oral Anti-Diabetic Drug Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Oral Anti-Diabetic Drug Manufacturing Cost Structure
Figure 45. Oral Anti-Diabetic Drug Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries